The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hickman, H. D.
Right arrow Articles by Hildebrand, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hickman, H. D.
Right arrow Articles by Hildebrand, W. H.
The Journal of Immunology, 2003, 171: 22-26.
Copyright © 2003 by The American Association of Immunologists


CUTTING EDGE

Cutting Edge: Class I Presentation of Host Peptides Following HIV Infection1

Heather D. Hickman*, Angela D. Luis*, Wilfried Bardet*, Rico Buchli*, Casey L. Battson{dagger}, Michael H. Shearer2,*, Kenneth W. Jackson{dagger}, Ronald C. Kennedy2,* and William H. Hildebrand3,*

* Department of Microbiology and Immunology and {dagger} William K. Warren Medical Research Institute, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104

Class I MHC molecules bind intracellular peptides for presentation to cytotoxic T lymphocytes. Identification of peptides presented by class I molecules during infection is therefore a priority for detecting and targeting intracellular pathogens. To understand which host-encoded peptides distinguish HIV-infected cells, we have developed a mass spectrometric approach to characterize HLA-B*0702 peptides unique to or up-regulated on infected T cells. In this study, we identify 15 host proteins that are differentially presented on infected human T cells. Peptides with increased expression on HIV-infected cells were derived from multiple categories of cellular proteins including RNA binding proteins and cell cycle regulatory proteins. Therefore, comprehensive analysis of the B*0702 peptide repertoire demonstrates that marked differences in host protein presentation occur after HIV infection.




This article has been cited by other articles:


Home page
JEMHome page
M.-H. Fortier, E. Caron, M.-P. Hardy, G. Voisin, S. Lemieux, C. Perreault, and P. Thibault
The MHC class I peptide repertoire is molded by the transcriptome
J. Exp. Med., March 17, 2008; 205(3): 595 - 610.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. W. Yewdell and H. D. Hickman
New lane in the information highway: alternative reading frame peptides elicit T cells with potent antiretrovirus activity
J. Exp. Med., October 29, 2007; 204(11): 2501 - 2504.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Rolland, M. A. Jensen, D. C. Nickle, J. Yan, G. H. Learn, L. Heath, D. Weiner, and J. I. Mullins
Reconstruction and Function of Ancestral Center-of-Tree Human Immunodeficiency Virus Type 1 Proteins
J. Virol., August 15, 2007; 81(16): 8507 - 8514.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
H. D. Meiring, E. C. Soethout, M. C. M. Poelen, D. Mooibroek, R. Hoogerbrugge, H. Timmermans, C. J. Boog, A. J. R. Heck, A. P. J. M. de Jong, and C. A. C. M. van Els
Stable Isotope Tagging of Epitopes: A Highly Selective Strategy For The Identification Of Major Histocompatibility Complex Class I-Associated Peptides Induced Upon Viral Infection
Mol. Cell. Proteomics, May 1, 2006; 5(5): 902 - 913.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. D. Mason, M. I. Bowmer, C. M. Howley, and M. D. Grant
Cross-Reactive Cytotoxic T Lymphocytes against Human Immunodeficiency Virus Type 1 Protease and Gamma Interferon-Inducible Protein 30
J. Virol., May 1, 2005; 79(9): 5529 - 5536.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
X.-L. Huang, Z. Fan, B. A. Colleton, R. Buchli, H. Li, W. H. Hildebrand, and C. R. Rinaldo Jr.
Processing and Presentation of Exogenous HLA Class I Peptides by Dendritic Cells from Human Immunodeficiency Virus Type 1-Infected Persons
J. Virol., March 1, 2005; 79(5): 3052 - 3062.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
A. W. Purcell and J. J. Gorman
Immunoproteomics: Mass Spectrometry-based Methods to Study the Targets of the Immune Response
Mol. Cell. Proteomics, March 1, 2004; 3(3): 193 - 208.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. D. Hickman, A. D. Luis, R. Buchli, S. R. Few, M. Sathiamurthy, R. S. VanGundy, C. F. Giberson, and W. H. Hildebrand
Toward a Definition of Self: Proteomic Evaluation of the Class I Peptide Repertoire
J. Immunol., March 1, 2004; 172(5): 2944 - 2952.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.